Semler Scientific (NASDAQ:SMLR) Stock Price Down 6.3% - Time to Sell?

Key Points

• Semler Scientific's stock fell by 6.3% on Friday, trading at $36.43, significantly below its previous close of $38.89.
• Research analysts have varied opinions on the stock, with Wall Street Zen downgrading it to a "sell" rating while Benchmark set a price target of $101.00.
• The company's latest earnings report showed a (0.76) EPS and revenues of $8.84 million, indicating financial challenges with a negative net margin of 60.69%.
• Institutional investors and hedge funds own approximately 49.37% of Semler Scientific's stock, indicating significant market interest despite the recent drop.

Semler Scientific Inc. (NASDAQ:SMLR - Get Free Report)'s stock price fell 6.3% during trading on Friday . The company traded as low as $37.26 and last traded at $36.43. 60,799 shares changed hands during trading, a decline of 91% from the average session volume of 696,389 shares. The stock had previously closed at $38.89.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on SMLR. Cantor Fitzgerald began coverage on shares of Semler Scientific in a research report on Monday. They set an "overweight" rating and a $61.00 target price on the stock. Maxim Group raised shares of Semler Scientific to a "strong-buy" rating and set a $95.00 target price on the stock in a research report on Wednesday, July 9th. Benchmark began coverage on shares of Semler Scientific in a research report on Tuesday, July 8th. They set a "buy" rating and a $101.00 target price on the stock. Finally, Wall Street Zen lowered shares of Semler Scientific from a "buy" rating to a "sell" rating in a research report on Thursday, May 22nd. One research analyst has rated the stock with a sell rating, three have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $82.00.

Semler Scientific Trading Down 6.8%

The company has a market capitalization of $504.64 million, a PE ratio of -14.02 and a beta of 1.39. The company's fifty day moving average is $38.68 and its 200-day moving average is $40.57. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.52 and a quick ratio of 0.51.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its quarterly earnings data on Tuesday, May 13th. The company reported ($0.76) earnings per share (EPS) for the quarter. The business had revenue of $8.84 million for the quarter. Semler Scientific had a negative net margin of 60.69% and a positive return on equity of 19.75%.

Hedge Funds Weigh In On Semler Scientific

Several institutional investors and hedge funds have recently bought and sold shares of SMLR. BNP Paribas Financial Markets purchased a new position in Semler Scientific in the fourth quarter worth $30,000. Summit Securities Group LLC purchased a new position in Semler Scientific in the first quarter worth $32,000. SBI Securities Co. Ltd. grew its holdings in Semler Scientific by 161.3% in the first quarter. SBI Securities Co. Ltd. now owns 959 shares of the company's stock worth $35,000 after purchasing an additional 592 shares during the last quarter. NewEdge Advisors LLC grew its holdings in Semler Scientific by 318.3% in the fourth quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock worth $40,000 after purchasing an additional 557 shares during the last quarter. Finally, Legal & General Group Plc grew its holdings in Semler Scientific by 65.4% in the fourth quarter. Legal & General Group Plc now owns 2,056 shares of the company's stock worth $111,000 after purchasing an additional 813 shares during the last quarter. 49.37% of the stock is owned by hedge funds and other institutional investors.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.